In glomerular diseases, such as Alport syndrome and diabetic nephropathy, the pathological changes in the GBM result from both altered matrix component synthesis and defective MMP degradation50,51 and our results suggest a similar mechanism is occurring in the absence of CD151. Here, CD151 is linked to Alport syndrome.